Noradrenalin Abcur (Noradrenaline Tartrate)

Norepinephrine stimulates alpha‑1 and alpha‑2 adrenergic receptors, causing peripheral vasoconstriction that raises systemic vascular resistance and arterial pressure. It also activates beta‑1 receptors in the heart, increasing heart rate and contractility, which together improve cardiac output and tissue perfusion during shock states.

The dose of Noradrenalin Abcur is individualized and set by the prescribing clinician. It is typically administered as a continuous intravenous infusion that is titrated to achieve target blood‑pressure goals, with the exact rate depending on the patient’s response and clinical condition.

Safety data for Noradrenalin Abcur in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To order Noradrenalin Abcur, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and necessary import documentation.

Noradrenalin Abcur is the first‑line vasopressor for most shock states because of its potent alpha‑adrenergic vasoconstriction and modest beta‑1 cardiac stimulation. Compared with dopamine, it has a more predictable pressor effect and lower risk of tachyarrhythmias. Epinephrine provides stronger beta‑adrenergic activity but may increase lactate production and cause more tachycardia.

Noradrenalin Abcur must be stored refrigerated at 2‑8 °C. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the solution. Before use, inspect for particulate matter or discoloration and discard any product that appears compromised.

The medication is supplied as a sterile injection solution for intravenous infusion. It is typically administered through a central venous catheter or a large‑bore peripheral line, using an infusion pump to allow precise rate adjustments based on continuous hemodynamic monitoring.

Serious risks include severe hypertension that can precipitate stroke or myocardial ischemia, arrhythmias such as ventricular tachycardia, tissue necrosis from extravasation at the infusion site, and cardiac arrest. Prompt recognition and immediate intervention are essential if any of these events occur.

Noradrenalin Abcur should be avoided in patients with known hypersensitivity to norepinephrine or any of its excipients. Caution is advised in individuals with severe peripheral vascular disease, uncontrolled hypertension, or those receiving MAO inhibitors, as the risk of excessive vasoconstriction is heightened.